Arvest Bank Trust Division’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.7M Sell
58,889
-719
-1% -$57.5K 0.2% 74
2025
Q4
$5.68M Sell
59,608
-64,955
-52% -$6.37M 0.31% 64
2025
Q3
$12.2M Sell
124,563
-702
-0.6% -$72.7K 0.67% 42
2025
Q2
$13.5M Buy
125,265
+204
+0.2% +$20.6K 0.78% 37
2025
Q1
$12.6M Buy
+125,061
New +$12.6M 0.8% 42

Other funds holding BSX

Arvest Bank Trust Division's BSX Position: Q1 2026 in Review

Arvest Bank Trust Division reduced its Boston Scientific (BSX) stake by 1.2% in Q1 2026, selling an estimated $57.5K and leaving 58,889 shares worth $3.7M. The position accounts for 0.2% of the portfolio, ranked #74.

Arvest Bank Trust Division first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $13.5M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Arvest Bank Trust Division held 58,889 shares of Boston Scientific worth $3.7M as of Q1 2026.
  • Arvest Bank Trust Division sold 719 Boston Scientific shares in Q1 2026, an estimated $57.5K.
  • Boston Scientific made up 0.2% of Arvest Bank Trust Division's portfolio in Q1 2026, its #74 holding.
  • Arvest Bank Trust Division first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
  • Arvest Bank Trust Division's Boston Scientific position peaked at $13.5M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Arvest Bank Trust Division's 13F filing for Q1 2026, filed 13 May 2026.